ADVERTISEMENT

UPDATE ON PELVIC FLOOR DYSFUNCTION

OBG Management. 2011 October;23(10):17-28
October 1, 2011|OBG Management
Cindy L. Amundsen, MD;Amie Kawasaki, MD
Author and Disclosure Information


Amie Kawasaki, MD
Dr. Kawasaki is Fellow in the Division of Female Pelvic Medicine and Reconstructive Surgery, and Clinical Instructor of Obstetrics and Gynecology, at Duke University Medical Center in Durham, NC.


Cindy L. Amundsen, MD
Dr. Amundsen is Associate Professor and Fellowship Director of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, at Duke University Medical Center in Durham, NC.

The authors report that they have no financial relationships relevant to this article.

We need to expand the differential diagnosis for chronic pelvic pain to include pelvic myofascial pain

IN THIS ARTICLE

Sacral neuromodulation is not FDA-approved for the treatment of chronic pelvic pain; further studies are needed before it can be recommended for this indication.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

Neither of these studies required objective evidence of myofascial pain for inclusion. Therefore, although the benefits they demonstrated may be theorized to extend to the relief of myofascial pain, this fact cannot be corroborated.

We want to hear from you! Tell us what you think.

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT